MedPath

MINT-RIVAROXABAN

MINT-RIVAROXABAN

Approved
DIN Number

02515253

Drug Class

Human

Market Date

N/A

Company
HC

mint pharmaceuticals inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02515253
AIG Number0152487003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
B01AF01 RIVAROXABAN
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification20:12.04.14
Health Canada Classification

ACTIVE INGREDIENTS (1)

RIVAROXABANActive
Strength: 20 MG
Monograph: RIVAROXABAN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.